Bionomics Limited (ASX:BNO, BNOOA, US OTC: BMICY) announced today that it has received a two-year extension and an additional $859,000 in funding on its Federal Government R&D START grant for its central nervous system (CNS) drug development program. The original $2.87m grant awarded in 2003 has now been boosted to $3.73m and extended to June 30, 2007.
